Wave Life Sciences has become the inaugural industry sponsor of AlphaDetect, a nonprofit focused on expanding genetic testing for Alpha-1 Antitrypsin Deficiency (Alpha-1), a progressive liver and lung disease. AlphaDetect offers free genetic testing and support to healthcare providers to improve early detection, which is currently underdiagnosed in over 90% of cases. This partnership aims to enhance awareness, provider education, and detection strategies, helping patients receive timely care and access to resources. The initiative aligns with clinical guidelines recommending testing for individuals with COPD, asthma, or unexplained liver disease, addressing a significant gap in current medical practice.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Frasers Group PLC has withheld financial guidance for the upcoming year due to uncertainty around its takeover bids for Hugo Boss and Accent Group. The retailer's full-year adjusted profit before tax fell 4% to £538 million, impacted by asset impairm...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
